Literature DB >> 28956179

miR-149 promotes human osteocarcinoma progression via targeting bone morphogenetic protein 9 (BMP9).

Zikang Xie1, Jianda Xu1, Libo Peng1, Yi Gao1, Hong Zhao1, Yuxing Qu2.   

Abstract

OBJECTIVES: To investigate the roles of miR-149 in the progression of human osteosarcoma (OS).
RESULTS: miR-149 level was upregulated in tissues from OS patients more than in normal subjects. Cell proliferation and apoptosis assays revealed that miR-149 increased cell proliferation and inhibited cell apoptosis in OS cell line (MG63). An increase of Bcl-2 gene expression and a decrease of cleaved-caspase-3, and cleaved-PARP expression were observed in MG63 cells with transfection of miR-149. Additionally, bone morphogenetic protein 9 (BMP9) was identified as a target of miR-149 in MG63 cells, and BMP9 expression was negatively correlated with miR149 level in OS clinical samples. Co-overexpression of BMP9 with miR-149 in MG63 cells prohibited miR-149-mediated promotive effects on OS progression. Importantly, overexpression of miR-149 conferred chemoresistance in MG63 cells.
CONCLUSIONS: miR-149 promotes OS progression via targeting BMP9.

Entities:  

Keywords:  Bcl-2; Bone morphogenetic protein 9; MG63 cells; Osteosarcoma; miR-149

Mesh:

Substances:

Year:  2017        PMID: 28956179     DOI: 10.1007/s10529-017-2445-8

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  7 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

Review 2.  Regulation and functions of MicroRNA-149 in human cancers.

Authors:  Yingru Zhi; Hao Zhou; Abudoureyimu Mubalake; Ying Chen; Bei Zhang; Kai Zhang; Xiaoyuan Chu; Rui Wang
Journal:  Cell Prolif       Date:  2018-07-12       Impact factor: 6.831

3.  Bone morphogenetic protein 9, and its genetic variants contribute to susceptibility of idiopathic pulmonary arterial hypertension.

Authors:  Kefang Guo; Liying Xu; Lin Jin; Huilin Wang; Yun Ren; Yan Hu; Jing Yu; Jing Cang
Journal:  Aging (Albany NY)       Date:  2020-02-07       Impact factor: 5.682

4.  Long non-coding RNA-H19 stimulates osteogenic differentiation of bone marrow mesenchymal stem cells via the microRNA-149/SDF-1 axis.

Authors:  Guangjie Li; Xiangdong Yun; Kaishan Ye; Haiyan Zhao; Jiangdong An; Xueliang Zhang; Xingwen Han; Yanhong Li; Shuanke Wang
Journal:  J Cell Mol Med       Date:  2020-03-21       Impact factor: 5.310

Review 5.  The wonders of BMP9: From mesenchymal stem cell differentiation, angiogenesis, neurogenesis, tumorigenesis, and metabolism to regenerative medicine.

Authors:  Sami Mostafa; Mikhail Pakvasa; Elam Coalson; Allen Zhu; Alex Alverdy; Hector Castillo; Jiaming Fan; Alex Li; Yixiao Feng; Di Wu; Elliott Bishop; Scott Du; Mia Spezia; Alissa Li; Ofir Hagag; Alison Deng; Winny Liu; Mingyang Li; Sherwin S Ho; Aravind Athiviraham; Michael J Lee; Jennifer Moriatis Wolf; Guillermo A Ameer; Hue H Luu; Rex C Haydon; Jason Strelzow; Kelly Hynes; Tong-Chuan He; Russell R Reid
Journal:  Genes Dis       Date:  2019-07-24

6.  MicroRNA‑149 inhibits cancer cell malignant phenotype by regulating Akt1 in C4‑2 CRPC cell line.

Authors:  Jiahui Zhao; Qiankun Li; Bingfu Feng; Dechao Wei; Yili Han; Mingchuan Li; Yongxing Wang; Yong Luo; Yongguang Jiang
Journal:  Oncol Rep       Date:  2021-10-26       Impact factor: 3.906

7.  Research Progress of MicroRNA in Chemotherapy Resistance of Osteosarcoma.

Authors:  Zhaopeng Tang; Yubao Lu; Yutong Chen; Jiarui Zhang; Zhijun Chen; Qianfeng Wang
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.